FDA-approved branded GLP-1 medications Wegovy and Ozempic (semaglutide, Novo Nordisk), Mounjaro and Zepbound (tirzepatide, Eli Lilly), Saxenda (liraglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), Victoza (liraglutide) underwent the SUSTAIN, STEP, SURPASS, and SURMOUNT trial programs and are reviewed by the FDA as finished drug products
It indicates normal physiological variation that masks ongoing fat loss
Triple-hormone receptor agonist retatrutide for obesity treatment
Dark, tarry, or maroon-colored blood is more concerning and should be evaluated promptly
Daily dosing compensates by providing frequent small amounts that accumulate to therapeutic levels over time
Bedrosian explains, "Ozempic will help you lose a lot of weight in a relatively short period of time